In situ forming parenteral depot systems based on poly(ethylene carbonate): Effect of polymer molecular weight on model protein release
[Display omitted] The objective of this study was to investigate the effect of molecular weight (MW) on the drug release from poly(ethylene carbonate) (PEC) based surface-eroding in situ forming depots (ISFD). In phosphate buffered saline (PBS) pH 7.4, 63.7% of bovine serum albumin BSA was released...
Saved in:
Published in | European journal of pharmaceutics and biopharmaceutics Vol. 85; no. 3; pp. 1245 - 1249 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.11.2013
|
Subjects | |
Online Access | Get full text |
ISSN | 0939-6411 1873-3441 1873-3441 |
DOI | 10.1016/j.ejpb.2013.05.020 |
Cover
Abstract | [Display omitted]
The objective of this study was to investigate the effect of molecular weight (MW) on the drug release from poly(ethylene carbonate) (PEC) based surface-eroding in situ forming depots (ISFD). In phosphate buffered saline (PBS) pH 7.4, 63.7% of bovine serum albumin BSA was released from high MW PEC of 200kDa (PEC200) in DMSO (15%, w/w) in 2days, while during the same time period, the release of BSA from PEC41 samples was only 22.5%. At higher concentrations of PEC41 (25%, w/w), the initial burst was further reduced, and even after 6days, only 16.3% was released. Compared to depots based on PEC200, there was lower rate of solvent release, slower phase inversion, and a denser surface in PEC41 samples. An expansion in size of PEC41 depots suggested that the polymer barrier of PEC41 impeded the diffusion of solvent out of the samples effectively. In conclusion, the initial burst of protein from ISFD of PEC41 was significantly reduced, which would be a promising candidate as polymeric carrier. |
---|---|
AbstractList | [Display omitted]
The objective of this study was to investigate the effect of molecular weight (MW) on the drug release from poly(ethylene carbonate) (PEC) based surface-eroding in situ forming depots (ISFD). In phosphate buffered saline (PBS) pH 7.4, 63.7% of bovine serum albumin BSA was released from high MW PEC of 200kDa (PEC200) in DMSO (15%, w/w) in 2days, while during the same time period, the release of BSA from PEC41 samples was only 22.5%. At higher concentrations of PEC41 (25%, w/w), the initial burst was further reduced, and even after 6days, only 16.3% was released. Compared to depots based on PEC200, there was lower rate of solvent release, slower phase inversion, and a denser surface in PEC41 samples. An expansion in size of PEC41 depots suggested that the polymer barrier of PEC41 impeded the diffusion of solvent out of the samples effectively. In conclusion, the initial burst of protein from ISFD of PEC41 was significantly reduced, which would be a promising candidate as polymeric carrier. The objective of this study was to investigate the effect of molecular weight (MW) on the drug release from poly(ethylene carbonate) (PEC) based surface-eroding in situ forming depots (ISFD). In phosphate buffered saline (PBS) pH 7.4, 63.7% of bovine serum albumin BSA was released from high MW PEC of 200 kDa (PEC200) in DMSO (15%, w/w) in 2 days, while during the same time period, the release of BSA from PEC41 samples was only 22.5%. At higher concentrations of PEC41 (25%, w/w), the initial burst was further reduced, and even after 6 days, only 16.3% was released. Compared to depots based on PEC200, there was lower rate of solvent release, slower phase inversion, and a denser surface in PEC41 samples. An expansion in size of PEC41 depots suggested that the polymer barrier of PEC41 impeded the diffusion of solvent out of the samples effectively. In conclusion, the initial burst of protein from ISFD of PEC41 was significantly reduced, which would be a promising candidate as polymeric carrier.The objective of this study was to investigate the effect of molecular weight (MW) on the drug release from poly(ethylene carbonate) (PEC) based surface-eroding in situ forming depots (ISFD). In phosphate buffered saline (PBS) pH 7.4, 63.7% of bovine serum albumin BSA was released from high MW PEC of 200 kDa (PEC200) in DMSO (15%, w/w) in 2 days, while during the same time period, the release of BSA from PEC41 samples was only 22.5%. At higher concentrations of PEC41 (25%, w/w), the initial burst was further reduced, and even after 6 days, only 16.3% was released. Compared to depots based on PEC200, there was lower rate of solvent release, slower phase inversion, and a denser surface in PEC41 samples. An expansion in size of PEC41 depots suggested that the polymer barrier of PEC41 impeded the diffusion of solvent out of the samples effectively. In conclusion, the initial burst of protein from ISFD of PEC41 was significantly reduced, which would be a promising candidate as polymeric carrier. The objective of this study was to investigate the effect of molecular weight (MW) on the drug release from poly(ethylene carbonate) (PEC) based surface-eroding in situ forming depots (ISFD). In phosphate buffered saline (PBS) pH 7.4, 63.7% of bovine serum albumin BSA was released from high MW PEC of 200 kDa (PEC200) in DMSO (15%, w/w) in 2 days, while during the same time period, the release of BSA from PEC41 samples was only 22.5%. At higher concentrations of PEC41 (25%, w/w), the initial burst was further reduced, and even after 6 days, only 16.3% was released. Compared to depots based on PEC200, there was lower rate of solvent release, slower phase inversion, and a denser surface in PEC41 samples. An expansion in size of PEC41 depots suggested that the polymer barrier of PEC41 impeded the diffusion of solvent out of the samples effectively. In conclusion, the initial burst of protein from ISFD of PEC41 was significantly reduced, which would be a promising candidate as polymeric carrier. |
Author | Beck-Broichsitter, Moritz Chu, Dafeng Kissel, Thomas Curdy, Catherine Riebesehl, Bernd |
Author_xml | – sequence: 1 givenname: Dafeng surname: Chu fullname: Chu, Dafeng organization: Department of Pharmaceutics and Biopharmacy, Philipps-Universität, Marburg, Germany – sequence: 2 givenname: Catherine surname: Curdy fullname: Curdy, Catherine organization: Novartis Pharma AG, Basel, Switzerland – sequence: 3 givenname: Bernd surname: Riebesehl fullname: Riebesehl, Bernd organization: Novartis Pharma AG, Basel, Switzerland – sequence: 4 givenname: Moritz surname: Beck-Broichsitter fullname: Beck-Broichsitter, Moritz organization: Department of Pharmaceutics and Biopharmacy, Philipps-Universität, Marburg, Germany – sequence: 5 givenname: Thomas surname: Kissel fullname: Kissel, Thomas email: kissel@staff.uni-marburg.de organization: Department of Pharmaceutics and Biopharmacy, Philipps-Universität, Marburg, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23791717$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kcFu1DAQhi1URLcLL8AB-VgOCXbixAnigqoClSpxgbM1scetV44dbG_RPgGvTZYtHDj0NBrp-2ak_78gZyEGJOQ1ZzVnvH-3q3G3THXDeFuzrmYNe0Y2fJBt1QrBz8iGje1Y9YLzc3KR844xJmQ3vCDnTStHLrnckF83gWZX9tTGNLtwRxdIGAom8NTgEgvNh1xwznSCjIbGQJfoD5dY7g8eA1INaYoBCr59T6-tRV1otH-YGROdo0e995DoT3R39-Xoz9Ggp0uKBV2gCT2ul1-S5xZ8xlePc0u-f7r-dvWluv36-ebq422l264vFfSaM9M1VloLU9-DYWIUnTEGDNphMpoNorPD0DENYl251ABWGN4wkFa0W3J5urv-_7HHXNTsskbvIWDcZ8VF33EpxzW6LXnziO6nGY1akpshHdTf8FagOQE6xZwT2n8IZ-rYkNqpY0Pq2JBinVobWqXhP0m7AsXFUBI4_7T64aTiGtCDw6Sydhg0GpfW3JWJ7in9N7Hgr48 |
CitedBy_id | crossref_primary_10_1016_j_polymdegradstab_2018_11_018 crossref_primary_10_3390_pharmaceutics13050605 crossref_primary_10_1016_j_progpolymsci_2018_01_006 crossref_primary_10_1016_j_ejpb_2017_02_011 crossref_primary_10_1080_13102818_2015_1063453 crossref_primary_10_1016_j_msec_2018_05_046 crossref_primary_10_3390_pharmaceutics15102401 crossref_primary_10_1016_j_ijbiomac_2018_11_098 crossref_primary_10_1016_j_matdes_2015_09_138 crossref_primary_10_1016_j_ijpharm_2016_07_075 crossref_primary_10_1016_j_jconrel_2014_03_048 crossref_primary_10_1016_j_ijpharm_2022_121603 |
Cites_doi | 10.1016/j.jconrel.2010.08.020 10.1016/S0168-3659(97)00097-7 10.1016/j.ejpb.2010.07.009 10.1016/j.ejpb.2004.03.003 10.1016/S0168-3659(01)00417-5 10.1002/mabi.201000496 10.1016/0168-3659(94)00083-7 10.1016/j.jconrel.2012.04.016 10.1016/j.biomaterials.2005.09.017 10.1016/j.jconrel.2005.10.005 10.1016/j.biomaterials.2008.09.038 10.1016/j.jconrel.2003.08.010 10.1016/j.jconrel.2005.09.038 10.1002/jbm.a.32724 10.1016/j.ijpharm.2003.06.002 10.1002/jps.21415 10.1016/j.biomaterials.2009.03.033 10.1007/s11095-009-9969-0 10.1016/j.jconrel.2010.01.001 10.1016/j.ejps.2008.03.004 10.1016/S0168-3659(98)00158-8 10.1002/(SICI)1097-4636(20000605)50:3<388::AID-JBM13>3.0.CO;2-F |
ContentType | Journal Article |
Copyright | 2013 Elsevier B.V. Copyright © 2013 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2013 Elsevier B.V. – notice: Copyright © 2013 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.ejpb.2013.05.020 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-3441 |
EndPage | 1249 |
ExternalDocumentID | 23791717 10_1016_j_ejpb_2013_05_020 S0939641113002282 |
Genre | Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 29G 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATCM AAXUO AAYOK ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ABYKQ ABZDS ACDAQ ACGFO ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC C45 CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SDF SDG SES SEW SPCBC SSP SSU SSZ T5K TEORI UNMZH ~G- AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP BNPGV CITATION SSH CGR CUY CVF ECM EIF NPM 7X8 EFKBS |
ID | FETCH-LOGICAL-c356t-a6c10d52f7ffab66ad04945dddadef8bdc0845f8850ca4bdc17caaf4d120a7f43 |
IEDL.DBID | AIKHN |
ISSN | 0939-6411 1873-3441 |
IngestDate | Fri Sep 05 13:21:37 EDT 2025 Thu Apr 03 06:59:45 EDT 2025 Tue Jul 01 00:58:36 EDT 2025 Thu Apr 24 22:59:31 EDT 2025 Fri Feb 23 02:28:04 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Drug release Water swelling Poly(ethylene carbonate) Surface-eroding polymers Initial burst In situ forming depots |
Language | English |
License | Copyright © 2013 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c356t-a6c10d52f7ffab66ad04945dddadef8bdc0845f8850ca4bdc17caaf4d120a7f43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 23791717 |
PQID | 1465177909 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_1465177909 pubmed_primary_23791717 crossref_primary_10_1016_j_ejpb_2013_05_020 crossref_citationtrail_10_1016_j_ejpb_2013_05_020 elsevier_sciencedirect_doi_10_1016_j_ejpb_2013_05_020 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2013-11-01 |
PublicationDateYYYYMMDD | 2013-11-01 |
PublicationDate_xml | – month: 11 year: 2013 text: 2013-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | European journal of pharmaceutics and biopharmaceutics |
PublicationTitleAlternate | Eur J Pharm Biopharm |
PublicationYear | 2013 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Packhaeuser, Schnieders, Oster, Kissel (b0050) 2004; 58 Patel, Carlson, Solorio, Exner (b0095) 2010; 94 Astaneh, Erfan, Moghimi, Mobedi (b0100) 2009; 98 Stoll, Nimmerfall, Acemoglu, Bodmer, Bantle, Muller, Mahl, Kolopp, Tullberg (b0005) 2001; 76 Acemoglu, Nimmerfall, Bantle, Stoll (b0035) 1997; 49 Patel, Solorio, Wu, Krupka, Exner (b0090) 2010; 147 Solorio, Babin, Patel, Mach, Azar, Exner (b0085) 2010; 143 Zhang, Kuijer, Bulstra, Grijpma, Feijen (b0020) 2006; 27 Luan, Bodmeier (b0080) 2006; 110 Bege, Renette, Jansch, Reul, Merkel, Petersen, Curdy, Müller, Kissel (b0040) 2011; 11 Eliaz, Kost (b0105) 2000; 50 Dadsetan, Christenson, Unger, Ausborn, Kissel, Hiltner, Andersona (b0015) 2003; 93 Bat, van Kooten, Feijen, Grijpma (b0030) 2009; 30 McHugh (b0070) 2005; 109 Kempe, Mäder (b0055) 2012; 161 Inoue, Tsuruta, Takada, Miyazaki, Kambe, Takaoka (b0060) 1975; 26 Chapanian, Tse, Pang, Amsden (b0025) 2009; 30 Schoenhammer, Petersen, Guethlein, Goepferich (b0065) 2009; 26 Graham, Brodbeck, McHugh (b0075) 1999; 58 Kranz, Bodmeier (b0115) 2008; 34 Lambert, Peck (b0110) 1995; 33 Liu, Kemmer, Keim, Curdy, Petersen, Kissel (b0045) 2010; 76 Acemoglu (b0010) 2004; 277 Bat (10.1016/j.ejpb.2013.05.020_b0030) 2009; 30 McHugh (10.1016/j.ejpb.2013.05.020_b0070) 2005; 109 Liu (10.1016/j.ejpb.2013.05.020_b0045) 2010; 76 Schoenhammer (10.1016/j.ejpb.2013.05.020_b0065) 2009; 26 Acemoglu (10.1016/j.ejpb.2013.05.020_b0035) 1997; 49 Kranz (10.1016/j.ejpb.2013.05.020_b0115) 2008; 34 Packhaeuser (10.1016/j.ejpb.2013.05.020_b0050) 2004; 58 Chapanian (10.1016/j.ejpb.2013.05.020_b0025) 2009; 30 Luan (10.1016/j.ejpb.2013.05.020_b0080) 2006; 110 Patel (10.1016/j.ejpb.2013.05.020_b0090) 2010; 147 Patel (10.1016/j.ejpb.2013.05.020_b0095) 2010; 94 Graham (10.1016/j.ejpb.2013.05.020_b0075) 1999; 58 Eliaz (10.1016/j.ejpb.2013.05.020_b0105) 2000; 50 Inoue (10.1016/j.ejpb.2013.05.020_b0060) 1975; 26 Lambert (10.1016/j.ejpb.2013.05.020_b0110) 1995; 33 Solorio (10.1016/j.ejpb.2013.05.020_b0085) 2010; 143 Zhang (10.1016/j.ejpb.2013.05.020_b0020) 2006; 27 Kempe (10.1016/j.ejpb.2013.05.020_b0055) 2012; 161 Acemoglu (10.1016/j.ejpb.2013.05.020_b0010) 2004; 277 Astaneh (10.1016/j.ejpb.2013.05.020_b0100) 2009; 98 Stoll (10.1016/j.ejpb.2013.05.020_b0005) 2001; 76 Dadsetan (10.1016/j.ejpb.2013.05.020_b0015) 2003; 93 Bege (10.1016/j.ejpb.2013.05.020_b0040) 2011; 11 |
References_xml | – volume: 58 start-page: 445 year: 2004 end-page: 455 ident: b0050 article-title: In situ forming parenteral drug delivery systems: an overview publication-title: Eur. J. Pharm. Biopharm. – volume: 98 start-page: 135 year: 2009 end-page: 145 ident: b0100 article-title: Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behavior publication-title: J. Pharm. Sci. – volume: 26 start-page: 257 year: 1975 end-page: 267 ident: b0060 article-title: Synthesis and thermal degradation of carbon dioxide–epoxide copolymer publication-title: Appl. Polym. Symp. – volume: 143 start-page: 183 year: 2010 end-page: 190 ident: b0085 article-title: Noninvasive characterization of in situ forming implants using diagnostic ultrasound publication-title: J. Control. Release – volume: 34 year: 2008 ident: b0115 article-title: Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles publication-title: Eur. J. Pharm. Sci. – volume: 49 start-page: 263 year: 1997 end-page: 276 ident: b0035 article-title: Poly(ethylene carbonate)s, Part I: Syntheses and structural effects on biodegradation publication-title: J. Control. Release – volume: 30 start-page: 3652 year: 2009 end-page: 3661 ident: b0030 article-title: Macrophage-mediated erosion of gamma irradiated poly(trimethylene carbonate) films publication-title: Biomaterials – volume: 147 start-page: 350 year: 2010 end-page: 358 ident: b0090 article-title: Effect of injection site on in situ implant formation and drug release in vivo publication-title: J. Control. Release – volume: 11 start-page: 897 year: 2011 end-page: 904 ident: b0040 article-title: Biodegradable poly(ethylene carbonate) nanoparticles as a promising drug delivery system with “Stealth” potential publication-title: Macromol. Biosci. – volume: 109 start-page: 211 year: 2005 end-page: 221 ident: b0070 article-title: The role of polymer membrane formation in sustained release drug delivery systems publication-title: J. Control. Release – volume: 161 start-page: 668 year: 2012 end-page: 679 ident: b0055 article-title: In situ forming implants – an attractive formulation principle for parenteral depot formulations publication-title: J. Control. Release – volume: 30 start-page: 295 year: 2009 end-page: 306 ident: b0025 article-title: The role of oxidation and enzymatic hydrolysis on the in vivo degradation of trimethylene carbonate based photocrosslinkable elastomers publication-title: Biomaterials – volume: 58 start-page: 233 year: 1999 end-page: 245 ident: b0075 article-title: Phase inversion dynamics of PLGA solutions related to drug delivery publication-title: J. Control. Release – volume: 33 start-page: 189 year: 1995 end-page: 195 ident: b0110 article-title: Development of an in situ forming biodegradable poly-lactide-coglycolide system for the controlled release of proteins publication-title: J. Control. Release – volume: 110 start-page: 266 year: 2006 end-page: 272 ident: b0080 article-title: Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems publication-title: J. Control. Release – volume: 93 start-page: 259 year: 2003 end-page: 270 ident: b0015 article-title: In vivo biocompatibility and biodegradation of poly(ethylene carbonate) publication-title: J. Control. Release – volume: 76 start-page: 209 year: 2001 end-page: 225 ident: b0005 article-title: Poly(ethylene carbonate)s: Part II. Degradation mechanisms and parenteral delivery of bioactive agents publication-title: J. Control. Release – volume: 277 start-page: 133 year: 2004 end-page: 139 ident: b0010 article-title: Chemistry of polymer biodegradation and implications on parenteral drug delivery publication-title: Int. J. Pharm. – volume: 50 start-page: 388 year: 2000 end-page: 396 ident: b0105 article-title: Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins publication-title: J. Biomed. Mater. Res. – volume: 27 start-page: 1741 year: 2006 end-page: 1748 ident: b0020 article-title: The in vivo and in vitro degradation behavior of poly(trimethylene carbonate) publication-title: Biomaterials – volume: 76 start-page: 222 year: 2010 end-page: 229 ident: b0045 article-title: Poly(ethylene carbonate) as a surface-eroding biomaterial for in situ forming parenteral drug delivery systems: a feasibility study publication-title: Eur. J. Pharm. Biopharm. – volume: 94 start-page: 476 year: 2010 end-page: 484 ident: b0095 article-title: Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems publication-title: J. Biomed. Mater. Res. A – volume: 26 start-page: 2568 year: 2009 end-page: 2577 ident: b0065 article-title: Poly(ethyleneglycol) 500 dimethylether as novel solvent for injectable in situ forming depots publication-title: Pharm. Res. – volume: 147 start-page: 350 year: 2010 ident: 10.1016/j.ejpb.2013.05.020_b0090 article-title: Effect of injection site on in situ implant formation and drug release in vivo publication-title: J. Control. Release doi: 10.1016/j.jconrel.2010.08.020 – volume: 49 start-page: 263 year: 1997 ident: 10.1016/j.ejpb.2013.05.020_b0035 article-title: Poly(ethylene carbonate)s, Part I: Syntheses and structural effects on biodegradation publication-title: J. Control. Release doi: 10.1016/S0168-3659(97)00097-7 – volume: 76 start-page: 222 year: 2010 ident: 10.1016/j.ejpb.2013.05.020_b0045 article-title: Poly(ethylene carbonate) as a surface-eroding biomaterial for in situ forming parenteral drug delivery systems: a feasibility study publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2010.07.009 – volume: 58 start-page: 445 year: 2004 ident: 10.1016/j.ejpb.2013.05.020_b0050 article-title: In situ forming parenteral drug delivery systems: an overview publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2004.03.003 – volume: 76 start-page: 209 year: 2001 ident: 10.1016/j.ejpb.2013.05.020_b0005 article-title: Poly(ethylene carbonate)s: Part II. Degradation mechanisms and parenteral delivery of bioactive agents publication-title: J. Control. Release doi: 10.1016/S0168-3659(01)00417-5 – volume: 11 start-page: 897 year: 2011 ident: 10.1016/j.ejpb.2013.05.020_b0040 article-title: Biodegradable poly(ethylene carbonate) nanoparticles as a promising drug delivery system with “Stealth” potential publication-title: Macromol. Biosci. doi: 10.1002/mabi.201000496 – volume: 33 start-page: 189 year: 1995 ident: 10.1016/j.ejpb.2013.05.020_b0110 article-title: Development of an in situ forming biodegradable poly-lactide-coglycolide system for the controlled release of proteins publication-title: J. Control. Release doi: 10.1016/0168-3659(94)00083-7 – volume: 161 start-page: 668 year: 2012 ident: 10.1016/j.ejpb.2013.05.020_b0055 article-title: In situ forming implants – an attractive formulation principle for parenteral depot formulations publication-title: J. Control. Release doi: 10.1016/j.jconrel.2012.04.016 – volume: 27 start-page: 1741 year: 2006 ident: 10.1016/j.ejpb.2013.05.020_b0020 article-title: The in vivo and in vitro degradation behavior of poly(trimethylene carbonate) publication-title: Biomaterials doi: 10.1016/j.biomaterials.2005.09.017 – volume: 110 start-page: 266 year: 2006 ident: 10.1016/j.ejpb.2013.05.020_b0080 article-title: Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems publication-title: J. Control. Release doi: 10.1016/j.jconrel.2005.10.005 – volume: 30 start-page: 295 year: 2009 ident: 10.1016/j.ejpb.2013.05.020_b0025 article-title: The role of oxidation and enzymatic hydrolysis on the in vivo degradation of trimethylene carbonate based photocrosslinkable elastomers publication-title: Biomaterials doi: 10.1016/j.biomaterials.2008.09.038 – volume: 93 start-page: 259 year: 2003 ident: 10.1016/j.ejpb.2013.05.020_b0015 article-title: In vivo biocompatibility and biodegradation of poly(ethylene carbonate) publication-title: J. Control. Release doi: 10.1016/j.jconrel.2003.08.010 – volume: 109 start-page: 211 year: 2005 ident: 10.1016/j.ejpb.2013.05.020_b0070 article-title: The role of polymer membrane formation in sustained release drug delivery systems publication-title: J. Control. Release doi: 10.1016/j.jconrel.2005.09.038 – volume: 94 start-page: 476 year: 2010 ident: 10.1016/j.ejpb.2013.05.020_b0095 article-title: Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems publication-title: J. Biomed. Mater. Res. A doi: 10.1002/jbm.a.32724 – volume: 277 start-page: 133 year: 2004 ident: 10.1016/j.ejpb.2013.05.020_b0010 article-title: Chemistry of polymer biodegradation and implications on parenteral drug delivery publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2003.06.002 – volume: 26 start-page: 257 year: 1975 ident: 10.1016/j.ejpb.2013.05.020_b0060 article-title: Synthesis and thermal degradation of carbon dioxide–epoxide copolymer publication-title: Appl. Polym. Symp. – volume: 98 start-page: 135 year: 2009 ident: 10.1016/j.ejpb.2013.05.020_b0100 article-title: Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behavior publication-title: J. Pharm. Sci. doi: 10.1002/jps.21415 – volume: 30 start-page: 3652 year: 2009 ident: 10.1016/j.ejpb.2013.05.020_b0030 article-title: Macrophage-mediated erosion of gamma irradiated poly(trimethylene carbonate) films publication-title: Biomaterials doi: 10.1016/j.biomaterials.2009.03.033 – volume: 26 start-page: 2568 year: 2009 ident: 10.1016/j.ejpb.2013.05.020_b0065 article-title: Poly(ethyleneglycol) 500 dimethylether as novel solvent for injectable in situ forming depots publication-title: Pharm. Res. doi: 10.1007/s11095-009-9969-0 – volume: 143 start-page: 183 year: 2010 ident: 10.1016/j.ejpb.2013.05.020_b0085 article-title: Noninvasive characterization of in situ forming implants using diagnostic ultrasound publication-title: J. Control. Release doi: 10.1016/j.jconrel.2010.01.001 – volume: 34 year: 2008 ident: 10.1016/j.ejpb.2013.05.020_b0115 article-title: Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2008.03.004 – volume: 58 start-page: 233 year: 1999 ident: 10.1016/j.ejpb.2013.05.020_b0075 article-title: Phase inversion dynamics of PLGA solutions related to drug delivery publication-title: J. Control. Release doi: 10.1016/S0168-3659(98)00158-8 – volume: 50 start-page: 388 year: 2000 ident: 10.1016/j.ejpb.2013.05.020_b0105 article-title: Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins publication-title: J. Biomed. Mater. Res. doi: 10.1002/(SICI)1097-4636(20000605)50:3<388::AID-JBM13>3.0.CO;2-F |
SSID | ssj0004758 |
Score | 2.1541903 |
Snippet | [Display omitted]
The objective of this study was to investigate the effect of molecular weight (MW) on the drug release from poly(ethylene carbonate) (PEC)... The objective of this study was to investigate the effect of molecular weight (MW) on the drug release from poly(ethylene carbonate) (PEC) based... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1245 |
SubjectTerms | Animals Biocompatible Materials - chemistry Cattle Chemistry, Pharmaceutical - methods Diffusion Drug Delivery Systems Drug release Drug Stability Hydrogen-Ion Concentration In situ forming depots Infusions, Parenteral Initial burst Microscopy, Electron, Scanning Molecular Weight Particle Size Poly(ethylene carbonate) Polyethylenes - chemistry Polymers - chemistry Serum Albumin, Bovine - chemistry Solvents - chemistry Surface-eroding polymers Viscosity Water - chemistry Water swelling |
Title | In situ forming parenteral depot systems based on poly(ethylene carbonate): Effect of polymer molecular weight on model protein release |
URI | https://dx.doi.org/10.1016/j.ejpb.2013.05.020 https://www.ncbi.nlm.nih.gov/pubmed/23791717 https://www.proquest.com/docview/1465177909 |
Volume | 85 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBbp5tJL6bubtmEKJbQ07lq25EdvITRsWhoCTSA3IUsybEjsZddL2Euu_dudkewshTaHHi00stCMNSN55vsYe1_qVJa6chF6qzwSqOKoLG0SxaKqLcEXVYJqh3-cZNNz8e1CXmyxw6EWhtIq-70_7Ol-t-5bJv1qTuaz2eQnDlRmgqjSPYgL7sPbCbbIEds-OP4-PdmUR-aeppP6RyTQ186ENC93Oa8owyv1AJ5E-_13__Sv-NP7oaPH7FEfQMJBmOMTtuWap2zvNCBQr_fhbFNQtdyHPTjdYFOvn7Ffxw0sZ90KKFZFrwWUgE5ri0NajMU7CNDOSyD3ZqFtYN5erT841Cf6JwdGLyq6cHcfv0BAPoa29n2u3QKuB7JduPFXriTvuXbA40HMGiCOFhz5OTs_-np2OI16LobIpDLrIp0ZHluZ1Hld6yrLtCVgGWmt1dbVRWVNXAhZF4WMjRb4yHOjdS0sT2Kd1yJ9wUZN27hXDHiSOFcap1NbCMO1LnDZY2tzVJ61VTZmfNCAMj1QOfFlXKkhI-1SkdYUaU3FUqH4mH26k5kHmI57e8tBseoPY1PoR-6VezdYgcKvkH6t6Ma1qyUdoCQn6MZyzF4G87ibR5LmeCbm-c5_vvU1e0hPoQDyDRt1i5V7i5FQV-2yB59v-W5v778BYJIK-g |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqcoAL4s1CgUFCFYiGzcOOE26ootpCW1ViK_Vm-Slt1Sar3ayqvXDlb-Oxk66QoAeOSWYcyzOZGTsz3xDyrpYFq6WyifdWPKFexEldmzxJqXIG4YsUxdrh45Nycka_nbPzLbI_1MJgWmVv-6NND9a6vzPuV3M8n83GP_xAdUmxVXoAcfF2-A5lBce8vk8_N3kelIcmnUidIHlfOROTvOzFXGF-VxHgO7Hp99-907-iz-CFDh6Q-334CF_iDB-SLds8IrunEX96vQfTTTnVcg924XSDTL1-TH4dNrCcdSvASNX7LMD0c1xZP6TxkXgHEdh5CejcDLQNzNvL9Xvrpem9kwUtFwqP2-2HzxBxj6F1gebKLuBqaLUL1-HAFflDpx0IaBCzBrBDix_5CTk7-DrdnyR9J4ZEF6zsElnqLDUsd9w5qcpSGoSVYcYYaayrlNFpRZmrKpZqSf1lxrWUjposTyV3tHhKtpu2sc8JZHluba2tLExFdSZl5Zc9NYZ7YRqjyhHJBgkI3cOUY7eMSzHko10IlJpAqYmUCc8-Ih9veOYRpONWajYIVvyhasJ7kVv53g5aIPw3iD9WZGPb1RK3TyxD4MZ6RJ5F9biZR15wvyPO-Iv_fOsbcncyPT4SR4cn31-Se_gklkLukO1usbKvfEzUqddB538Dq5sLxQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+situ+forming+parenteral+depot+systems+based+on+poly%28ethylene+carbonate%29%3A+effect+of+polymer+molecular+weight+on+model+protein+release&rft.jtitle=European+journal+of+pharmaceutics+and+biopharmaceutics&rft.au=Chu%2C+Dafeng&rft.au=Curdy%2C+Catherine&rft.au=Riebesehl%2C+Bernd&rft.au=Beck-Broichsitter%2C+Moritz&rft.date=2013-11-01&rft.issn=1873-3441&rft.eissn=1873-3441&rft.volume=85&rft.issue=3+Pt+B&rft.spage=1245&rft_id=info:doi/10.1016%2Fj.ejpb.2013.05.020&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0939-6411&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0939-6411&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0939-6411&client=summon |